Valuation: Celltrion, Inc.

Market Cap 41,027B 30.52B 27.25B 25.42B 23.09B 43.46B 2,956B 43.88B 305B 119B 1,502B 115B 112B 4,830B P/E 2026 *
27.2x
P/E 2027 * 23.3x
Enterprise Value 43.17B 32.11M 28.67M 26.75M 24.3M 45.73M 3.11B 46.17M 321M 126M 1.58B 121M 118M 5.08B EV / Sales 2026 *
7.73x
EV / Sales 2027 * 6.64x
Free-Float
60.59%
Yield 2026 *
0.42%
Yield 2027 * 0.43%
1 day-2.13%
1 week+1.07%
Current month+1.07%
1 month-3.60%
3 months+0.79%
6 months-2.64%
Current year+4.19%
1 week 179,500
Extreme 179500
186,800
1 month 174,600
Extreme 174600
186,800
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 120,791.91
Extreme 120791.906503
239,047.62
5 years 114,250.83
Extreme 114250.828535
239,047.62
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 20/03/2015
Chief Executive Officer 42 26/03/2021
President 51 13/02/2026
Director TitleAgeSince
Chairman 69 -
Director/Board Member 61 01/04/2005
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
16/1/26 Sell 500 0.0002%
16/1/26 Sell 1,000 0.0004%
16/1/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-2.13%+1.07%+7.51%+50.31% 31.29B
-3.19%-3.19%+44.60%+87.98% 74.68B
-15.86%-16.16%+2.68%+51.09% 58.7B
-2.39%+0.50%+3.41%+31.33% 48.36B
-8.33%-9.67%+288.93%+630.21% 43.05B
-0.60%-1.91%+27.49%+28.17% 42.48B
-4.71%-3.38%-1.26%+100.63% 41.39B
-2.71%-4.18%-12.68%-15.10% 23.93B
-2.45%-9.08%-38.98%+302.84% 22.22B
-5.27%+1.86%+12.19%-3.32% 22.24B
Average -4.80%-1.75%+33.39%+126.41% 40.83B
Weighted average by Cap. -5.34%-1.44%+40.52%+125.99%

Financials

2026 *2027 *
Net sales 5,586B 4.16B 3.71B 3.46B 3.14B 5.92B 402B 5.97B 41.56B 16.25B 204B 15.6B 15.26B 658B 6,364B 4.73B 4.23B 3.94B 3.58B 6.74B 458B 6.81B 47.34B 18.52B 233B 17.77B 17.39B 749B
Net income 1,538B 1.14B 1.02B 953M 866M 1.63B 111B 1.64B 11.44B 4.47B 56.29B 4.29B 4.2B 181B 1,780B 1.32B 1.18B 1.1B 1B 1.89B 128B 1.9B 13.24B 5.18B 65.16B 4.97B 4.86B 210B
Net Debt 2,141B 1.59B 1.42B 1.33B 1.21B 2.27B 154B 2.29B 15.93B 6.23B 78.38B 5.98B 5.85B 252B 1,251B 931M 831M 775M 704M 1.33B 90.13B 1.34B 9.31B 3.64B 45.8B 3.49B 3.42B 147B
Projected Income Statement - Annual - Celltrion, Inc.
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
08/10/26 ₩179,600.00 -2.13% 445,268
07/10/26 ₩183,500.00 +0.60% 254,258
06/10/26 ₩182,400.00 -0.11% 346,310
02/10/26 ₩182,600.00 -0.54% 319,980
01/10/26 ₩183,600.00 +3.32% 422,088
Trader
Investor
Global
Quality
ESG MSCI
A
Ratings Surperformance© - Celltrion, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
179,600.00KRW
Average target price
267,741.48KRW
Spread / Average Target
+49.08%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Celltrion, Inc.
  1. Stock Market
  2. Stocks
  3. A068270 Stock